Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control
- PMID: 16366421
Efficacy of a novel calcium/potassium salt of (-)-hydroxycitric acid in weight control
Abstract
The weight-loss efficacy of a novel, water-soluble, calcium-potassium salt of (-)-hydroxycitric acid (HCA-SX) was re-examined in 90 obese subjects (BMI: 30-50.8 kg/m2). We combined data from two previously reported randomized, double-blind, placebo-controlled clinical studies in order to achieve a better statistical evaluation based on a larger population. This re-examination of data also allowed us to reflect more intensely on various aspects of weight loss studies. Subjects were randomly divided into three groups: group A received a daily dose of HCA-SX 4, 667 mg (providing 2,800 mg HCA per day); group B was given a daily dose of a combination of HCA-SX 4,667 mg, niacin-bound chromium (NBC) 4 mg (providing 400 microg elemental chromium), and Gymnema sylvestre extract (GSE) 400 mg (providing 100 mg gymnemic acid); and group C received a placebo in three equally divided doses 30-60 min before each meal. All subjects were provided a 2,000 kcal diet/day and participated in a supervised walking program for 30 min/day, 5 days/week. Eighty-two subjects completed the study. At the end of 8 weeks, in group A, both body weight and BMI decreased by 5.4%, low-density lipoprotein and triglycerides levels were reduced by 12.9% and 6.9%, respectively, while high-density lipoprotein levels increased by 8.9%, serum leptin levels decreased by 38%, serotonin levels increased by 44.5% and urinary excretion of fat metabolites increased by 32-109%. Group B demonstrated similar beneficial changes, but generally to a greater extent. No significant adverse effects were observed. The combined results confirm that HCA-SX and, to a greater degree, the combination of HCA-SX plus NBC and GSE reduce body weight and BMI, suppress appetite, improve blood lipid profiles, increase serum leptin and serotonin levels and increase fat oxidation more than placebo. We conclude that dosage levels, timing of administration, subject compliance and bioavailability of HCA-SX significantly affect results and that when taken as directed, HCA-SX is a highly effective adjunct to healthy weight control.
Similar articles
-
Effects of a natural extract of (-)-hydroxycitric acid (HCA-SX) and a combination of HCA-SX plus niacin-bound chromium and Gymnema sylvestre extract on weight loss.Diabetes Obes Metab. 2004 May;6(3):171-80. doi: 10.1111/j.1462-8902.2004.00328.x. Diabetes Obes Metab. 2004. PMID: 15056124 Clinical Trial.
-
An overview of the safety and efficacy of a novel, natural(-)-hydroxycitric acid extract (HCA-SX) for weight management.J Med. 2004;35(1-6):33-48. J Med. 2004. PMID: 18084863 Review.
-
Bioefficacy of a novel calcium-potassium salt of (-)-hydroxycitric acid.Mutat Res. 2005 Nov 11;579(1-2):149-62. doi: 10.1016/j.mrfmmm.2005.02.021. Epub 2005 Aug 1. Mutat Res. 2005. PMID: 16055158 Review.
-
Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt.Food Chem Toxicol. 2004 Sep;42(9):1513-29. doi: 10.1016/j.fct.2004.04.014. Food Chem Toxicol. 2004. PMID: 15234082 Review.
-
Effect of three treatment schedules of recombinant methionyl human leptin on body weight in obese adults: a randomized, placebo-controlled trial.Diabetes Obes Metab. 2005 Nov;7(6):755-61. doi: 10.1111/j.1463-1326.2005.00468.x. Diabetes Obes Metab. 2005. PMID: 16219020 Clinical Trial.
Cited by
-
Nutrigenomic analysis of diet-gene interactions on functional supplements for weight management.Curr Genomics. 2008 Jun;9(4):239-51. doi: 10.2174/138920208784533638. Curr Genomics. 2008. PMID: 19452041 Free PMC article.
-
No evidence demonstrating hepatotoxicity associated with hydroxycitric acid.World J Gastroenterol. 2009 Aug 28;15(32):4087-9. doi: 10.3748/wjg.15.4087. World J Gastroenterol. 2009. PMID: 19705510 Free PMC article.
-
Updates on Antiobesity Effect of Garcinia Origin (-)-HCA.Evid Based Complement Alternat Med. 2013;2013:751658. doi: 10.1155/2013/751658. Epub 2013 Aug 6. Evid Based Complement Alternat Med. 2013. PMID: 23990846 Free PMC article.
-
Medicinal Potential of Garcinia Species and Their Compounds.Molecules. 2020 Oct 1;25(19):4513. doi: 10.3390/molecules25194513. Molecules. 2020. PMID: 33019745 Free PMC article. Review.
-
In vitro and in vivo toxicity of garcinia or hydroxycitric Acid: a review.Evid Based Complement Alternat Med. 2012;2012:197920. doi: 10.1155/2012/197920. Epub 2012 Aug 9. Evid Based Complement Alternat Med. 2012. PMID: 22924054 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical